Posted on October 27, 2014
Source: Health Data Management
The City of Baltimore Health Department and Baltimore-based mobile care platform developer emocha Mobile Health will be launching a pilot program aimed at easing the burden of tuberculosis care monitoring on the city's provider community.
The health department will use emocha’s medication adherence app, miDOT, to help tuberculosis patients adhere to their medication regimen while also fulfilling CDC-required Directly Observed Therapy (DOT).
DOT requires a clinician to physically observe a patient take their medication every day for at least six months. This is resource-intensive, costly to the system, and burdensome for the patient. miDOT serves as a proxy for DOT. Patients use emocha’s HIPAA-compliant smartphone app, miDOT, to record themselves taking their medication at their own convenience. miDOT captures symptoms and securely submits the video to the emocha server, where a clinician can then observe and confirm adherence on the emocha web interface.
